CROI 2022
The Conference on Retroviruses and Opportunistic Infections (CROI) took place from 12 to 16 February. CROI 2022 was held virtually this year due to coronavirus.
-
12-16 February 2022
-
Virtual
Nearly a third of babies with HIV given ART very soon after birth have no HIV antibodies two years later
Screening and early treatment reduce anal cancer risk by 57% in people living with HIV
Injected PrEP: cabotegravir maintains its advantage over four years
More focused HIV testing in PEPFAR countries yields results
New cases of hepatitis C declining in people with HIV as access to treatment broadens
COVID-19 vaccine rates in people with HIV mirror those in the general population
Point-of-care viral load tests did not improve viral suppression in Kenyan children
One person remains undetectable without HIV drugs almost four years after using an antibody-based therapy
New York woman is free of HIV 14 months after stem cell transplant
COVID-19 vaccine booster produces strong responses in people with HIV with low CD4 counts
Heart attack rates are declining, but not in people with HIV
Overall lifetime risk of being diagnosed with HIV in the US decreases by 11%, but stark racial and geographical disparities persist
Anticholinergic medications associated with falls and frailty in people ageing with HIV
COVID-19 raises the risk of adverse birth outcomes, especially in women with HIV
Could antibodies be used for children with HIV instead of pills?
Booster vaccine doses protect people with HIV against severe COVID-19
What led to the fall in HIV cases in UK gay men?
Zero vertical transmissions from over 5000 pregnant women with undetectable HIV in France